1 | receptors | 5,933 |
2 | potentials | 1,279 |
3 | bodies | 1,187 |
4 | transporters | 634 |
5 | neurotransmission | 363 |
6 | monophosphate | 269 |
7 | adhesin | 61 |
8 | disruptors | 47 |
9 | autoreceptors | 31 |
10 | disruptor | 21 |
11 | ammonis | 12 |
12 | synthetases | 11 |
13 | grain-soybean | 9 |
14 | releasers | 8 |
15 | amidinotransferase | 5 |
16 | neuroreceptors | 5 |
17 | body-associated | 4 |
18 | d2-receptors | 4 |
19 | grains/d | 4 |
20 | neurotransmissions | 4 |
21 | rhodosporidium | 4 |
22 | triphosphatases | 4 |
23 | -genotype | 3 |
24 | 1a9 | 3 |
25 | i-domains | 3 |
26 | phalerata | 3 |
27 | receptors-1 | 3 |
28 | 5-monophosphate | 2 |
29 | dihydrochloride/interleukin-2 | 2 |
30 | ex-novo | 2 |
31 | h1- | 2 |
32 | h2-receptors | 2 |
33 | i/hour | 2 |
34 | ii-antagonist | 2 |
35 | iiiα | 2 |
36 | kenalog | 2 |
37 | monophosphate- | 2 |
38 | ophtalmopathy | 2 |
39 | schmidli | 2 |
40 | subreceptors | 2 |
41 | -blocker-users | 1 |
42 | -hd | 1 |
43 | 2-hybridization | 1 |
44 | 5'-diphosphate- | 1 |
45 | 5'-methyluronamides | 1 |
46 | 5'deadenylase | 1 |
47 | addition/release | 1 |
48 | agonist±statin | 1 |
49 | allylamides | 1 |
50 | analgesics.1 | 1 |
51 | analouges | 1 |
52 | biodisponibility | 1 |
53 | blanch | 1 |
54 | body-adaptations | 1 |
55 | breads/rolls | 1 |
56 | cannabinoid- | 1 |
57 | care-group | 1 |
58 | chemicals—they | 1 |
59 | d4-antagonists | 1 |
60 | desynchronizations | 1 |
61 | disruptor-estrone-was | 1 |
62 | dl-50 | 1 |
63 | dose-shift | 1 |
64 | dph1 | 1 |
65 | grains/30-g | 1 |
66 | hypersignaling | 1 |
67 | ii-levels | 1 |
68 | ii-which | 1 |
69 | iiialpha | 1 |
70 | lysine27 | 1 |
71 | matter-nil | 1 |
72 | nano-powders | 1 |
73 | neuromodulations | 1 |
74 | neurosecretion | 1 |
75 | neurotranismision | 1 |
76 | oragans | 1 |
77 | polyautoaggressiveness | 1 |
78 | potential-p300 | 1 |
79 | psychotropism | 1 |
80 | rac-cis-4a-aralkyl- | 1 |
81 | receptor-antagonists | 1 |
82 | receptor.assessment | 1 |
83 | receptors/cd14 | 1 |
84 | rossii | 1 |
85 | scgrx3 | 1 |
86 | signal-transmission | 1 |
87 | transporter- | 1 |
88 | xa-inhibitors | 1 |
1 | -blocker-users | 1 |
2 | -genotype | 3 |
3 | -hd | 1 |
4 | 1a9 | 3 |
5 | 2-hybridization | 1 |
6 | 5'-diphosphate- | 1 |
7 | 5'-methyluronamides | 1 |
8 | 5'deadenylase | 1 |
9 | 5-monophosphate | 2 |
10 | addition/release | 1 |
11 | adhesin | 61 |
12 | agonist±statin | 1 |
13 | allylamides | 1 |
14 | amidinotransferase | 5 |
15 | ammonis | 12 |
16 | analgesics.1 | 1 |
17 | analouges | 1 |
18 | autoreceptors | 31 |
19 | biodisponibility | 1 |
20 | blanch | 1 |
21 | bodies | 1,187 |
22 | body-adaptations | 1 |
23 | body-associated | 4 |
24 | breads/rolls | 1 |
25 | cannabinoid- | 1 |
26 | care-group | 1 |
27 | chemicals—they | 1 |
28 | d2-receptors | 4 |
29 | d4-antagonists | 1 |
30 | desynchronizations | 1 |
31 | dihydrochloride/interleukin-2 | 2 |
32 | disruptor | 21 |
33 | disruptor-estrone-was | 1 |
34 | disruptors | 47 |
35 | dl-50 | 1 |
36 | dose-shift | 1 |
37 | dph1 | 1 |
38 | ex-novo | 2 |
39 | grain-soybean | 9 |
40 | grains/30-g | 1 |
41 | grains/d | 4 |
42 | h1- | 2 |
43 | h2-receptors | 2 |
44 | hypersignaling | 1 |
45 | i-domains | 3 |
46 | i/hour | 2 |
47 | ii-antagonist | 2 |
48 | ii-levels | 1 |
49 | ii-which | 1 |
50 | iiialpha | 1 |
51 | iiiα | 2 |
52 | kenalog | 2 |
53 | lysine27 | 1 |
54 | matter-nil | 1 |
55 | monophosphate | 269 |
56 | monophosphate- | 2 |
57 | nano-powders | 1 |
58 | neuromodulations | 1 |
59 | neuroreceptors | 5 |
60 | neurosecretion | 1 |
61 | neurotranismision | 1 |
62 | neurotransmission | 363 |
63 | neurotransmissions | 4 |
64 | ophtalmopathy | 2 |
65 | oragans | 1 |
66 | phalerata | 3 |
67 | polyautoaggressiveness | 1 |
68 | potential-p300 | 1 |
69 | potentials | 1,279 |
70 | psychotropism | 1 |
71 | rac-cis-4a-aralkyl- | 1 |
72 | receptor-antagonists | 1 |
73 | receptor.assessment | 1 |
74 | receptors | 5,933 |
75 | receptors-1 | 3 |
76 | receptors/cd14 | 1 |
77 | releasers | 8 |
78 | rhodosporidium | 4 |
79 | rossii | 1 |
80 | scgrx3 | 1 |
81 | schmidli | 2 |
82 | signal-transmission | 1 |
83 | subreceptors | 2 |
84 | synthetases | 11 |
85 | transporter- | 1 |
86 | transporters | 634 |
87 | triphosphatases | 4 |
88 | xa-inhibitors | 1 |
1 | h1- | 2 |
2 | cannabinoid- | 1 |
3 | 5'-diphosphate- | 1 |
4 | monophosphate- | 2 |
5 | rac-cis-4a-aralkyl- | 1 |
6 | transporter- | 1 |
7 | potential-p300 | 1 |
8 | dl-50 | 1 |
9 | receptors-1 | 3 |
10 | analgesics.1 | 1 |
11 | dph1 | 1 |
12 | dihydrochloride/interleukin-2 | 2 |
13 | scgrx3 | 1 |
14 | receptors/cd14 | 1 |
15 | lysine27 | 1 |
16 | 1a9 | 3 |
17 | iiialpha | 1 |
18 | phalerata | 3 |
19 | grains/d | 4 |
20 | body-associated | 4 |
21 | -hd | 1 |
22 | -genotype | 3 |
23 | addition/release | 1 |
24 | 5'deadenylase | 1 |
25 | amidinotransferase | 5 |
26 | monophosphate | 269 |
27 | 5-monophosphate | 2 |
28 | grains/30-g | 1 |
29 | hypersignaling | 1 |
30 | kenalog | 2 |
31 | ii-which | 1 |
32 | blanch | 1 |
33 | rossii | 1 |
34 | schmidli | 2 |
35 | matter-nil | 1 |
36 | psychotropism | 1 |
37 | rhodosporidium | 4 |
38 | grain-soybean | 9 |
39 | adhesin | 61 |
40 | agonist±statin | 1 |
41 | neurotranismision | 1 |
42 | signal-transmission | 1 |
43 | neurotransmission | 363 |
44 | 2-hybridization | 1 |
45 | neurosecretion | 1 |
46 | ex-novo | 2 |
47 | care-group | 1 |
48 | disruptor | 21 |
49 | i/hour | 2 |
50 | disruptor-estrone-was | 1 |
51 | allylamides | 1 |
52 | 5'-methyluronamides | 1 |
53 | analouges | 1 |
54 | bodies | 1,187 |
55 | triphosphatases | 4 |
56 | synthetases | 11 |
57 | ammonis | 12 |
58 | potentials | 1,279 |
59 | ii-levels | 1 |
60 | breads/rolls | 1 |
61 | oragans | 1 |
62 | i-domains | 3 |
63 | neurotransmissions | 4 |
64 | neuromodulations | 1 |
65 | body-adaptations | 1 |
66 | desynchronizations | 1 |
67 | nano-powders | 1 |
68 | releasers | 8 |
69 | -blocker-users | 1 |
70 | transporters | 634 |
71 | xa-inhibitors | 1 |
72 | receptors | 5,933 |
73 | d2-receptors | 4 |
74 | h2-receptors | 2 |
75 | subreceptors | 2 |
76 | neuroreceptors | 5 |
77 | autoreceptors | 31 |
78 | disruptors | 47 |
79 | polyautoaggressiveness | 1 |
80 | d4-antagonists | 1 |
81 | receptor-antagonists | 1 |
82 | dose-shift | 1 |
83 | receptor.assessment | 1 |
84 | ii-antagonist | 2 |
85 | chemicals—they | 1 |
86 | ophtalmopathy | 2 |
87 | biodisponibility | 1 |
88 | iiiα | 2 |